Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Elevated Markers of Inflammation Are Associated With Longitudinal Changes in Brain Function in Older Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2018
   Article
2. Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Molecular psychiatry · 2017
   Article
3. Commentary: Life course epidemiology embraces geroscience.International journal of epidemiology · 2016
   Article
4. Accelerating aging research: how can we measure the rate of biologic aging?Experimental gerontology · 2015
   Article

Corrections and comments

• Comment on
  Change in inflammatory markers and cognitive status in the oldest-old women from the Study of Osteoporotic Fractures.2014

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as